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ABSTRACT: PH46A, belonging to a class of 1,2-Indane dimers, has been developed by our research group as a potential
therapeutic agent for the treatment of inflammatory and autoimmune diseases. The initial synthetic route to PH46A gave a low
overall yield, due in large part to the generation of undesired diastereoisomer 5 and the unwanted enantiomer (R,R)-8 during the
synthesis. The aim of this work was to carry out a comprehensive investigation into the stereoselective synthesis of PH46A.
Significant progress was made on the ketone reduction step, where the use of triisobutylaluminum [TiBA, Al(iBu)3] afforded
high selectivity for the target diastereoisomer (rac)-6, compared to the unfavorable ratio obtained using a previous process. This
enabled a multikilo scale synthesis of PH46A in a GMP environment. Further, a brief proof-of-principle investigation was carried
out using an achiral phase transfer catalyst (PTC) for alkylation at the methine carbon of the parent indanone.
■ INTRODUCTION
The new chiral chemical entity PH46A, 6-(methylamino)-
hexane-1,2,3,4,5-pentanol 4-(((1S,2S)-1-hydroxy-2,3-dihydro-
1H,1′H-[2,2-biinden]-2-yl)methyl)benzoate, was previously
synthesized by our research group1 and shown to have
potential therapeutic activity in the areas of inflammation and
autoimmune diseases, including inflammatory bowel disease.2
PH46A recently completed a first-in-man Phase I clinical trial
study.3 The original synthetic route to this “first-in-class”
molecule included conventional organic chemistry and
preparative chiral HPLC separation (Scheme 1a).2
The overall yield of the original route (Scheme 1a) was less
than satisfactory, due to the generation of the undesired
diastereoisomer (rac)-5 and the unwanted enantiomer (R,R)-8.
The reduction of ketone 3 (step 3) was carried out using
sodium borohydride (NaBH4), which afforded a 60:40 ratio of
the unwanted diastereoisomer (rac)-5 and desired diaster-
eoisomer (rac)-6.2 Bulkier reagents, such as L-Selectride, gave
even greater selectivity for the undesired isomer, while
conceptually different reductants, such as DIP-chloride and
CBS reagent, gave poor conversion.4 The separation of
diastereoisomers 5 and 6 also proved challenging, especially
on larger scales, due to their similar chemical and physical
properties. Therefore, the development of a scalable stereo-
selective route for the synthesis of PH46A was desirable to
eliminate or reduce the cost burdens of generating the
undesired diastereoisomer and of carrying out a large scale
separation of the enantiomers. The current article describes our
initial work toward this goal, which underpinned the kilo-scale
GMP manufacture of PH46A. Further exploration is ongoing to
optimize the synthesis, and it is anticipated that a combination
of enantioselective alkylation to afford ketone 4 as a single
enantiomer and subsequent substrate-controlled diastereose-
lective reduction will ultimately lead to a highly stereoselective
synthesis of PH46A (Scheme 1b).
Our initial efforts were directed toward optimization of the
diastereoselectivity in step 3 (Scheme 1a), as even moderate
improvements could have immediate impact upon yields and
purification in planned scale-up work. Prior work had shown
NaBH4 in methyl tert-butyl ether (MTBE) to be unreactive,
probably due to the extremely low solubility of this reagent in
simple ethers solvents. NaBH4 in diglyme and LiBH4 in diethyl
ether, tetrahydrofuran (THF), and diglyme combinations were
briefly explored in this study, without leading to any significant
improvements. Meerwein−Ponndorf−Verley−Oppenauer
(MPVO) reduction and equilibration systems were also
investigated. Initial trial using aluminum(III) isopropoxide
(Al(OiPr)3) gave high selectivity in some cases; however, the
high dilution required and low reaction rate left a scalable
process out of reach. The use of neodymium(III) isopropoxide
(Nd(OiPr)3) along with a simple zeolite catalyst has been
reported to promote the racemization of chiral alcohols.5 When
applied to our system, a thermodynamic product distribution
was targeted as a result, in contrast to the kinetic product
mixture expected from metal borohydride reduction; however,
results were disappointing. Finally, a scalable, selective process
was developed using triisobutylaluminum, [TiBA, (Al(iBu)3)],
a reagent not often encountered as a carbonyl reducing agent.
The second part of this study comprised a brief investigation
of achiral phase transfer catalyst (PTC)-promoted benzylation
of ketone 3, to support future development of the
enantioselective variant, which had been identified as a
particularly interesting avenue of research.6 Unlike the use of
a chiral amide base, such PTC reactions are catalytic in the
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source of chiral information and typically do not require the
exclusion of air or moisture.7
■ RESULTS AND DISCUSSION
The absolute stereochemistry of PH46 (parent compound of
PH46A) had previously been established as an S configuration
at both C-1 and C-2.1 This configuration was shown to be
fundamental to the potent anti-inflammatory effects of the
molecule.2 For simplicity and clarity, the descriptors D1 (with
nontarget configuration, S,R and R,S) and D2 (with target
configuration, S,S and R,R) are used throughout the discussion
for the Me-, isopropyl (iPr)-, and tert-butyl (tBu)-ester
derivatives of hydroxyl acids 7 and 8. Reference standards for
all isomers were prepared independently to avoid ambiguity in
analyses. Experimental procedures and analytical data are given
in the Supporting Information (Figures S1 and S2).
Diastereoselective Reduction. Benchmark Reaction
Using NaBH4 in MeOH. A standard reduction of ketone
(rac)-4 was first carried out on a 5 g scale, using conditions
previously described.2 The reaction was complete in under 2 h,
resulting in the expected 3:2 diastereoisomeric mixture of D1
(5) and D2 (6) (Scheme 2 and Supporting Information Figures
S3 and S4).
Reduction with NaBH4 in Isopropanol (IPA) or Diglyme. As
noted in the introduction, previous work in our group had
shown that bulky reducing agents increased selectivity toward
the unwanted diastereoisomer 5. We considered that the poor
selectivity observed in reduction of ketone 4 using NaBH4/
MeOH might be attributable in part to rapid reaction of NaBH4
Scheme 1. (a) Original Synthetic Route to PH46A with Key Intermediates Generated from Steps 3 and 5; (b) Proposed
Stereoselective Synthesis of the Desired Isomer (S,S)-6
Scheme 2. Reduction of Ketone 4
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with MeOH to form various reductants of the general formula
HnB(OMe)(4−n),
8 in which one or more of the hydrides present
may be reactive, each potentially with differing selectivity as a
function of steric and electronic changes. Therefore, the effect
of a smaller reductant was explored, beginning with unmodified
NaBH4 in IPA (Table 1), a solvent which is largely unreactive
toward this reducing agent.9 However, all reactions were
extremely slow at rt and at 50 °C. In all cases, the initial
diastereoisomeric ratio (d.r.) D1/D2 (at rt or 50 °C) was
approximately 1:1. In addition, an extra set of peaks with longer
retention times (reversed phase HPLC) and with ratios roughly
corresponding to those of the starting material and expected
products was observed. These were identified as iPr-esters 9,
10, and 11; data for these products are given in the Supporting
Information (Scheme S1, Figures S5 and S6). As the
transesterification increased as a function of borohydride
stoichiometry, it appears that the process was promoted by a
boron-containing species. On extended heating (28 h), some
changes to d.r. were observed, with the desired isomer 6 being
predominant (D1/D2 up to 30:70) in entries 1C and 1D.
However, this was accompanied by increased levels of
byproduct formation (including some hydrolysis to the acids)
and it was not possible to determine whether this was a genuine
change in selectivity or the result of side reactions preferentially
removing diastereoisomer D1. Interestingly, at least two of the
hydrides of NaBH4 seemed to be active, given the conversions
in entries 1A and 1B.
Subsequent reactions were carried out in diglyme, chosen as
an aprotic solvent in which both NaBH4 and LiBH4 are soluble.
A pair of reactions (Table 2, entries 2A and 2B) were carried
out using NaBH4, both with and without TEA (1 equiv), which
has been reported4 to enhance reactivity. The reactions were
rather slow at rt and showed similar selectivity (at low
conversion) to the NaBH4/MeOH system. Higher conversa-
tion on heating was observed, but was accompanied by some
degradation. TEA had no significant effect in our system.
Reductions Using LiBH4. LiBH4 is often more versatile than
NaBH4 in reductions, as it is soluble in a greater range of
aprotic solvents, such as THF, diethyl ether, MTBE, and
diglyme. After an initial test with a large excess (5 equiv) of
LiBH4 in THF at rt overnight demonstrated that the ester was
resistant to reduction, a set of reactions in diglyme were carried
out (Table 2, entries 2C−2E) to allow direct comparison with
NaBH4. The results showed selectivity similar to that of NaBH4
in diglyme, but with higher reactivity. Given time, all the
hydrides of LiBH4 reacted, but no useful selectivity was
achieved under these conditions.
Meerwein−Ponndorf−Verley−Oppenauer (MPVO) Sys-
tem. The Meerwein−Ponndorf−Verley−Oppenauer reduction
is quite different from reductions using borohydride reagents.
First, the reaction is, in principle, entirely reversible.10 Second,
the steric requirements of the transition state can be quite
distinct from those of other hydride donors, as the MPVO
system has a six-membered transition state in which the
carbonyl group is coordinated to the metal of the reagent. The
reagent, usually Al(OiPr)3
11 or a lanthanide(III) isoprop-
oxide,12 is theoretically catalytic, but in the case of Al(OiPr)3
larger amounts (>1 equiv) are usually necessary for acceptable
rates. Initially, investigations of this system and variants were
planned with the aim of obtaining the thermodynamic product
rather than the kinetic product as expected from the use of
NaBH4 or other irreversible reducing agents. However, while
the reaction is reversible in principle, the equilibrium position
may not be reached due to other factors and so identification of
a thermodynamic product distribution is not trivial.
MPVO reductions with IPA as both solvent and hydride
donor are common, with the equilibrium being driven by the
vast excess of the alcohol present.13 Alternatively, toluene is
often used as the main solvent with a smaller excess of IPA. In
this case the equilibrium can be driven by loss of acetone to the
vapor phase at elevated temperature.14 Al(OiPr)3-promoted
MPVO reductions were first examined at rt and 75 °C (entries
3A−D, Table 3), using bulk-grade IPA as hydride donor.
Reactions were carried out below the reflux temperature for
either IPA or toluene, under which conditions acetone removal
would not have been efficient. As with reactions of NaBH4 in
IPA, these were accompanied by a high level of trans-
esterification to the iPr-esters. Although conversions were
low, entries 3B and 3C showed a surprising degree of selectivity
for the desired diastereoisomer, with a ratio of approximately
5:95 in favor of D2 (6 or 10) in each case. No further change
was observed on extended heating. Investigation showed that
the IPA used had a water content of >200 μg/mL, which at the
high dilutions used could well have resulted in reagent
degradation.
Further experiments were carried out (entries 4A−C, Table
3) using fresh HPLC-grade IPA with a water content <70 μg/
mL. As temperature and dilution were increased for this set of
reactions, direct comparisons could not be made, but the effect
on conversion appeared to be dramatic (compare entries 4A
and 3B). In entry 4B, where a larger excess of reagent was used,
conversion reached 90% HPLC area after overnight heating.
Use of substoichiometric Nd(OiPr)3 (entry 4C) was not
effective; stoichiometric use was not considered for cost
reasons. Entries 5 and 6A−6C were conducted in an effort to
Table 1. Reductions of Ketone 4 Using NaBH4 in IPA
a
D1/D2 ratio (area% conversion)
entry conditions 16 h/rtb +4 h/50 °Cc +28 h/50 °Cc
1A 0.25 equiv of NaBH4 50:50 (2%) 50:50 (10%) 47:53 (47%)
1B 0.5 equiv of NaBH4 48:52 (3%) 49:51 (17%) 42:58 (95%)
1C 1.0 equiv of NaBH4 46:54 (3%) 48:52 (34%) 42:58 (>99%)
d
1D 2.0 equiv of NaBH4 44:55 (6%) 48:52 (62%) 31:69 (>99%)
d
aConditions: IPA (100 mL/g). bRatios measured from Me-ester peaks
by HPLC. cRatios measured from iPr-ester peaks by HPLC.
dAccompanied by significant hydrolysis to 7 and 8 and other
byproducts.
Table 2. Reductions of Ketone 4 Using NaBH4 and LiBH4 in
Diglymea
D1/D2 ratio (area% conversion)
entry conditions 3 h/rtb overnight/rtb +8 h/90 °Cb,c
2A 1 equiv of NaBH4 58:42 (8%) 56:44 (12%) 46:54 (85%)
2B 1 equiv of NaBH4/
TEA
60:40 (5%) 56:44 (6%) 48:52 (>99%)
2C 0.25 equiv of LiBH4 63:37
(18%)
60:40 (31%) 54:46 (92%)
2D 0.5 equiv of LiBH4 61:39
(23%)
58:42 (49%) 50:50 (97%)
2E 1.0 equiv of LiBH4 60:40
(33%)
56:44 (79%) 51:49 (>99%)
aConditions: Diglyme (100 mL/g). bRatios measured from Me-ester
peaks by HPLC. cReduced accuracy due to byproduct formation.
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maximize conversion and improve the practicality of the
process. A reaction (entry 5) was carried out at 10 mmol scale
with greatly increased concentration (10 mL/g), which was
expected to avoid significant hydrolysis of the reagent by water
in the solvent. The temperature was also raised (made possible
by the higher reflux temperature of the more concentrated
mixture) to favor conversion by driving off the acetone
produced. However, conversion after overnight heating was
poor and the D1/D2 ratio was significantly worse than that
seen on smaller scales under more dilute conditions. Further
investigation on smaller scale (entries 6A−C, Table 3) was
conducted to determine whether this was a temperature or
concentration effect, with a high loading of reagent used to
favor the conversion, as in entry 4B. The results showed clearly
that increasing concentration led to poorer D1/D2 ratios, as
well as reduced conversion. We surmised that the increased
concentration favored the reverse reaction as a result of higher
acetone concentration, leading to both lower conversion and
more opportunity for equilibration of reaction products.
Though the hypothesis of a tendency toward an equilibrium
position was supported by the slow erosion of the D1/D2 ratio
with time in reaction entry 5, it is still possible that the
observed effect was simply due to changes to the nature (e.g.,
polarity and solvation) of the reaction environment.
To help understand the MPVO system further, scrambling of
a diastereoisomeric mixture of 5 and 6 (d.r. 60:40) using
catalytic Nd(OiPr)3 was investigated, with the aim of forming
the thermodynamic product by concurrent oxidation and
reduction (Scheme 3 and entry 7 in Table 3). A relatively high
loading of acetone (0.5 equiv) was used as the redox partner to
accelerate the reaction. To our surprise, along with the expected
formation of ketone 4, the undesired isomer 5 prevailed (D1/
D2, 89:11) after a relatively short reaction time (2.5 h). While
this suggests that diastereoisomer D1 is the thermodynamic
product, from this experiment alone we cannot rule out a
selective oxidation of the diastereoisomer D2. To our
knowledge, the relevant literature discusses this type of reaction
only in terms of racemization of a single stereocenter or
scrambling of a center remote from other stereocenters.5,12 Our
current hypothesis is that the MPVO reduction gives
diastereoisomer D2 as the kinetic product when IPA is in
vast excess (suppressing equilibration), but the “scrambling”
reaction (with oxidation via an Oppenauer-type process) does
indeed tend toward a thermodynamic equilibrium with
diastereoisomer D1 in excess. However, this has not been
unambiguously confirmed.
Reductions Using Al(iBu)3 as Reductant. Triisobutyl-
aluminum (commonly abbreviated as TiBA) is most commonly
encountered in the recent scientific literature as a polymer-
ization cocatalyst or reagent for aluminum deposition in
electronic applications. Nevertheless, it is also an effective
reducing agent for aldehydes and ketones. While the neat liquid
is pyrophoric, solutions in hexanes and toluene are both readily
handled and widely available. Both the mechanism of reduction
(a 6-membered cyclic transition state, involving ketone
coordination to aluminum) and the steric demands using
TiBA are very similar to the MPVO reaction.11,15 The key
differences are that TiBA reduction is essentially irreversible
and that no ketone byproduct is formed, features which we
expected would help overcome the low conversions observed
with Al(OiPr)3 reductions at practical concentrations. How-
ever, the reduction product (the aluminate formed from the
Table 3. Reductions of Ketone 4 Using Al(OiPr)3 (Entries 3−6) and MPVO-Scrambling of Mixture 5/6 Using Nd(OiPr)3
(Entry 7)a
D1/D2 ratio (area% conversion)
entry conditions 2 h 5.5 h 16 h 22 h
3A 2 equiv of Al(OiPr)3, IPA (100 mL/g), rt n.r. n.r. n.r. n.r.
3B 2 equiv of Al(OiPr)3, IPA (100 mL/g), 75 °C − − 5:95 (28%)c n.c.
3C 2 equiv of Al(OiPr)3, IPA (5 equiv), TOL (100 mL/g), 75 °C − − 6:94 (7%)b n.c.
3D 2 equiv of Al(OiPr)3, TFA (2 equiv), IPA (5 equiv), TOL (100 mL/g), rt (<2%) − − n.c.
4A 2 equiv of Al(OiPr)3, IPA (150 mL/g), 95 °C (reflux) 5:95 (21%)
c 5:95 (47%)c − 5:95 (84%)c
4B 4 equiv of Al(OiPr)3, IPA (150 mL/g), 95 °C (reflux) 5:95 (44%)
c 5:95 (76%)c − 6:94 (90%)c
4C 0.2 equiv of Nd(OiPr)3, IPA (150 mL/g), 95 °C (reflux) 20:80 (<2%)
b 20:80 (2%)b − (12%)c23:77
5 2 equiv of Al(OiPr)3, IPA (10 mL/g), 110 °C (reflux) 12:88 (26%)
c 13:87 (42%)c − 23:77 (53%)c
6A 4 equiv of Al(OiPr)3, IPA (20 mL/g), 95 °C (reflux) − − − 20:80 (75%)c
6B 4 equiv of Al(OiPr)3, IPA (50 mL/g), 95 °C (reflux) − − − 11:89 (87%)c
6C 4 equiv of Al(OiPr)3, IPA (200 mL/g), 95 °C (reflux) − − − 5:95 (83%)c
7 Nd(OiPr)3 (0.2 equiv), acetone (0.5 equiv), TOL, 50 °C 89:11 − − −
aConditions: see table. bRatio measured from Me ester peaks at low conversion. cRatio measured from iPr-ester peaks at low conversion; TOL =
toluene; n.r. = no reaction; n.c. = no change; (−) = not determined. Scale: 1 mmol ketone 4 except for entry 5 (10 mmol).
Scheme 3. MPVO Scrambling of Diastereoisomer Mixture 5/6 Using a Neodymium(III) Catalyst
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alkoxide after ketone reduction) can itself undergo equilibration
via a MPVO-type mechanism if unreacted ketone is also
present.16 When applied to our system, essentially complete
conversion and a promising D1/D2 ratio (8:92) were achieved
(Table 4, entry 8A), also supporting our hypothesis that
diastereoisomer D2 is the kinetic product with reductions
which proceed through a MPVO-type transition state. Based on
the apparent efficiency and clean HPLC profile of this reaction,
this route was explored further (Table 4, entries 8B−D). Each
reaction was examined after 2 h, and after extended stirring at rt
to determine whether degradation or equilibration would occur.
Overall, the reaction appeared robust. Lower temperature and
slow reagent addition resulted in only small improvements to
d.e. (entry 8B). While spiking of extra ketone into the reaction
mixture (entry 8C) led to slight erosion of d.e. (presumably via
a slow MPVO-type equilibration), mixtures without significant
ketone present showed no changes with time. Excess reagent
(entry 8D) lead to no significant side products, although in this
case the D1/D2 ratio (11:89) was slightly less favorable. When
dichloromethane (DCM) was used as a solvent (entry 9A), the
diastereoselectivity proved to be slightly poorer. Rather
surprisingly, no conversion was observed in THF (entry 9B);
use of a coordinating solvent in this case may have disrupted
the coordination between the ketone and the reagent required
for reaction. Returning to toluene as solvent (entries 10A−D),
reactions proved largely insensitive to both concentration and
temperature; the slight increase in d.r. resulting from a much
lower reaction temperature did not warrant the use of cryogenic
cooling. With entry 10B chosen as the most suitable for scaling
up, entry 10D was performed on a 20 mmol scale. The crude
HPLC profile and product ratios were consistent as on a small
scale, and a crude yield of 94% was obtained after workup.
To test the scalability of the process further, a reaction at 100
g scale was successfully conducted under similar conditions to
those in entry 10B (Scheme 4). The diastereoselectivity of the
reaction proved unaffected by scale. Following isolation and an
unoptimized trituration purification, the 100 g reaction gave a
63% isolated yield of desired isomer D2 (98% d.e.). A detailed
reaction procedure and analytical results are given in the
Experimental Section.
Phase Transfer Catalyst (PTC)-Promoted Alkylation of
Ketone 3. Phase transfer catalysis has long been recognized as
a powerful tool in both industrial and academic settings. The
oft-quoted advantages include simple experimental operations
(typically without exclusion of air or moisture), mild reaction
conditions, the low cost of common reagents and catalysts, and
the amenability to large scale process chemistry.17 In our
original synthetic route, the quaternary center was introduced
in a KOtBu-promoted alkylation in tBuOH/diethyl ether, and
using methyl(4-bromomethyl)benzoate as an electrophile.2 It
was believed that this might readily be substituted by an achiral
PTC process, using cheaper and less sensitive reagents, and
potentially extended in future to an asymmetric process. In the
current study, a short-proof-of-concept investigation was
carried out using an achiral PTC. Given the potential instability
of the methyl ester functionality in methyl(4-bromomethyl)-
benzoate under typical phase-transfer conditions, a more robust
ester was chosen to simplify testing. tert-Butyl(4-bromo-
methyl)benzoate was prepared from 4-(bromomethyl)benzoic
acid according to the literature method using tert-butyl-2,2,2-
trichloroacetimidate (TBTA) in a mixture of cyclohexane/
DCM/THF at rt.18 This alkylating agent was used in PTC-
promoted alkylations of ketone 3 to afford keto tBu-ester 12
(Figure 1). Standard conditions were chosen, using 25% aq.
NaOH/toluene (1:5) and tetrabutylammonium iodide (TBAI)
Table 4. Reductions of Ketone 4 Using Al(iBu)3
a
D1/D2 ratiob (area% conversion)
entry conditions 2 h +72 h
8A 1 equiv of Al(iBu)3 (2 min addn), TOL (25 mL/g), 5 °C, 30 min, then rt 8:92 (>99%) n.a.
8B 1 equiv of Al(iBu)3 (30 min addn), TOL (25 mL/g), −10 to 0 °C, 2 h, then rt 6:94 (92%) n.c.
8C 1 equiv of Al(iBu)3 (2 min addn), TOL (25 mL/g), −10 to 0 °C, 2 h, 0.5 equiv of 4 added, then rt 7:93 (97%) 13:87 (25%)
8D 2 equiv of Al(iBu)3 (30 min addn), TOL (25 mL/g), −10 to 0 °C, 2 h, then rt 11:89 (>99%) n.c.
9A 1 equiv of Al(iBu)3 (30 min addn), DCM (25 mL/g), 13:87 (>99%) n.c.
9B 1 equiv of Al(iBu)3 (30 min addn), THF (25 mL/g), <1% n.a.
10A 1 equiv of Al(iBu)3 (30 min addn), TOL (25 mL/g), −78 °C to rt, overnight 6:94 (>99%) n.a.
10B 1 equiv of Al(iBu)3 (30 min addn), TOL (12 mL/g), −10 to 0 °C, then rt 7:93 (>99%) n.a.
10C 1 equiv of Al(iBu)3 (30 min addn), TOL (50 mL/g), −10 to 0 °C, then rt 7:93 (>99%) n.a.
10D 1 equiv of Al(iBu)3 (60 min addn), TOL (12 mL/g), −10 to 0 °C, then rt 7:93 (>99%) n.a.
aConditions: see table. bRatio measured from Me ester peaks; TOL = toluene; n.a. = not applicable (reaction quenched at 2 h); n.c. = no change.
Scale: 1 mmol ketone 4 except for entry 10 C (0.5 mmol) and entry 10D (20 mmol).
Scheme 4. Reduction of Ketone 4 Using TiBA on 100 g Scale
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as the catalyst. Control reactions, without either ketone 3 or the
alkylating agent, were also carried out. Initially, no PTC was
added. HPLC analysis after 1 h of vigorous stirring showed
neither significant degradation nor any uncatalyzed alkylation.
Following addition of the PTC, the HPLC profile for the
reaction containing both ketone 3 and alkylating agent showed
rapid and clean conversion to the desired alkylation product 12.
The reaction was complete in under 3 h at ambient
temperature, while extended stirring had no effect on HPLC
profile. NMR spectra and HPLC chromatograms are given in
the Supporting Information (Figures S7−S9). While the
control reaction without ketone 3 showed no degradation of
the alkylating agent after 16 h, the reaction without alkylating
agent resulted in partial degradation of ketone 3, but the rate of
decomposition was sufficiently slow not to be a concern under
normal conditions. Among other species, the unsaturated
ketone 13 resulting from methanol elimination from 3 was
identified in the mixture. Although 13 is a potential
intermediate in the desired alkylation process, the species was
not observed in PTC- or KOtBu-promoted reactions, indicating
that, if formed, it is rapidly consumed in the presence of the
electrophile.
■ CONCLUSION
While investigation of the diastereoselective reduction of keto
Me-ester 4 using borohydride reagents failed to improve the
medchem route, exploration of Meerwein−Ponndorf−Verley
systems was more promising, affording the desired product in
good diastereoselectivity. Further investigations using the
related, and yet much less common, TiBA were more
successful, leading to a robust, selective, and scalable process
and insights into the kinetic vs thermodynamic products in our
system. This diastereoselective reduction method was success-
fully employed on multikilo scale in a GMP environment,
achieving up to 70% yield and >98% d.e. and purity (by area%).
Furthermore, the adoption of this step contributed toward a
20% overall cost reduction of the manufacturing of PH46A.
The GMP campaign will be described in detail in a separate
article.
Progress was also made toward replacing the original KOtBu-
promoted alkylation of 3 with a cost-effective, simpler process
using phase transfer catalysis. The reaction using a standard
achiral quaternary ammonium catalyst proved effective under
very simple conditions, though given time constraints this was
not scaled-up. Extension to an enantioselective variant is
currently under exploration in our laboratory.
■ EXPERIMENTAL SECTION
All solvents (as anhydrous, HPLC, or general process grades)
and reagents were purchased commercially and used as
received. Air-sensitive solutions in septum-sealed bottles were
dispensed under a balloon of nitrogen and capped immediately
after use. NMR spectra were recorded using a Varian 400 MHz
system and processed using MestreNova software. Chemical
shifts are quoted in ppm relative to tetramethylsilane as the
internal standard. Reversed phase (achiral) HPLC analyses
were conducted on an Agilent 1200 LC with a quaternary
pump, column oven, and diode array detector with data
processing using Chemstation software. Chromatographic
conditions: Zorbax C18 XDB column (150 mm × 4.6 mm)
5 μm; eluent A (water + 0.1% TFA v/v): B (MeOH) 20:80; 1.0
mL/min; column oven 40 °C; run time 15 min; injection
volume 5 μL; reference standard concentration: 1 mg/mL in
diluent. Sample preparation from PTC alkylations: reaction
mixture sample (2.5 μL) was diluted with IPA (1 mL). Sample
preparation from reductions: reaction mixture sample (5 μL)
was quenched with 3 M aq. HCl (100 μL) which was then
diluted with IPA (1 mL). For diastereoselective reductions,
Al(OiPr)3, Nd(OiPr)3, and LiBH4 were opened and stored in a
N2 glovebag (no active removal of moisture or oxygen other
than gentle N2 purging) for the duration of the project.
Representative Procedure for MPVO Reduction of
Methyl Ester 4 (Entry 4B). To a solution of keto Me-ester 4
(98 mg, 0.25 mmol) in IPA (15 mL) was added Al(OiPr)3 (204
mg, 0.5 mmol) in a single portion at rt. The reaction mixture
was purged with N2 and heated to gentle reflux. Conversion
was determined by reversed phase HPLC. When the reaction
was complete, the mixture was acidified using 1 M aq. HCl and
extracted with EtOAc. The organic phase was washed with
brine, dried over MgSO4, filtered, and concentrated to afford
the crude mixture of 9/10 as a hard foam.
MPVO “Scrambling” of Diastereoisomeric Mixture 5/6
(Entry 7). A mixture of 5 and 6 (D1/D2, 3:2, 396 mg, 1.0
mmol) was mixed in dry toluene (10 mL) in a flame-dried
reaction tube. Toluene was removed under reduced pressure.
The procedure was repeated with a second portion of dry
toluene (10 mL). The residue was taken up in dry toluene (10
mL), and Nd(OiPr)3 (63 mg, 0.2 mmol) was added. The tube
was purged with N2 and placed in an aluminum heating block
(block temperature 55 °C). Dry acetone (74 μL, 1 mmol) was
then added, resulting in a change of color from blue to yellow.
Conversion was determined by HPLC. The area ratio after 2.5
h at 55 °C was (D1/D2/11) 22:3:75. The reaction products
were not isolated.
100 g Scale-up Reduction of Keto Me-ester 4. Toluene
(1.2 L) and keto Me-ester 4 (99.1 g, 251 mmol) were charged
to the vessel, and the mixture was stirred (250 rpm) for 30 min
while the vessel atmosphere was purged with N2. The mixture
was cooled to an internal temperature of −12 °C. A solution of
Al(iBu)3 (1.1 M in toluene, 219 g, 288 mmol) was pumped into
the vessel through PTFE tubing over 1 h. The internal
temperature rose and steadied at −11 °C. After addition, the
reaction mixture was allowed to warm slowly with stirring for a
period of 2 h, reaching an internal temperature of 10 °C.
Addition of water (100 mL) resulted in a rise of the internal
temperature to 28 °C. Aq. HCl (1 M, 0.6 L) was added,
accompanied by a slight further exotherm to 29 °C. The
aqueous layer was discarded, and the organic phase was washed
further with aq. HCl (1 M, 0.3 L) and brine (0.3 L). The
organics were dried over MgSO4, filtered, and concentrated
under reduced pressure at 50 °C to afford crude 4 as a solid (95
g). The solid was triturated in MTBE (95 mL) for 2 h and left
to stand overnight at 5 °C. HPLC analysis of the supernatant at
this stage indicated a d.e. of 49%. The solid was collected by
filtration, washed with cold MTBE (95 mL in two portions),
Figure 1. Molecular structures of keto tBu-ester 12 and the
unsaturated ketone 13.
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and dried to afford diastereoisomer 6 (63 g, 63%) with 95%
purity and 98% d.e. The 1H NMR spectrum is given in Figure
2.
1H NMR (400 MHz, dmso-d6) δH (ppm): 7.70 (d, J = 8.4
Hz, 2H, Ar−H), 7.34−7.40 (m, 2H, Ar−H), 7.14−7.25 (m, 5H,
Ar−H), 7.07 (t, J = 14.4 Hz, 1H, Ar−H), 6.97 (d, J = 8.4 Hz,
2H, Ar−H), 6.39 (s, 1H, CH = C), 5.85 (d, J = 7.2 Hz, 1H,
CHOH), 5.06 (d, J = 6.8 Hz, 1H, CHOH), 3.77 (s, 3H, CH3),
3.56 (d, J = 23.2 Hz, 1H, CH2), 3.42 (d, J = 23.2 Hz, 1H, CH2),
3.20 (d, J = 13.6 Hz, 1H, CH2), 2.96 (s, 2H, CH2), 2.73 (d, J =
13.6 Hz, 1H, CH2).
General Procedure for PTC Alkylation. Ketone 3 (69
mg, 0.25 mmol) and tert-butyl(4-bromomethyl)benzoate (68
mg, 0.25 mmol) were taken up in toluene (2.5 mL) and
charged to a 20 mm diameter vial. TBAI (5 mg) and 25% aq.
NaOH (0.5 mL) were added, and the mixture was stirred at
1500 rpm overnight. The phases were separated, and the
toluene phase was concentrated under reduced pressure to
afford the crude product.
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